1270P Personalized tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in resected non-small cell lung cancer (NSCLC) with common driver genes

Ran Zhong(First Affiliated Hospital of Guangzhou Medical University), Jianxing He(First Affiliated Hospital of Guangzhou Medical University), Yu Jiang(Southwest Medical University), Wenhua Liang(First Affiliated Hospital of Guangzhou Medical University), Yu Lin, Zhou Ye(University of Hong Kong), Weiqi Fu(Nanjing Agricultural University), Rong Wang(Tang Hospital), Fei Li, Jiaqi Li(Shandong Provincial Hospital), Peng Chen(Shanghai Medical College of Fudan University), Xun Li(Guangzhou Medical University), Hui Wang(Hypertension Institute), Zhigang Yu(University of Michigan), Ying Xiong(China University of Geosciences), Yang Xiang, Shan Xiong, Xiangyi Zheng(Tianjin University), S. Zhan, Hengrui Liang(East China Normal University)
Annals of Oncology
October 1, 2023
10.1016/j.annonc.2023.09.748
Cited by 0

Related Papers

Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use
|Nature Genetics|2019|2.2k
Genetic diversity fuels gene discovery for tobacco and alcohol use
|Nature|2022|521
Visualizing RNA dynamics in live cells with bright and stable fluorescent RNAs
|Nature Biotechnology|2019|405
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
|Molecular Cancer|2020|383
Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry
|Journal of Clinical Oncology|2017|358